Evidence map›Paper›PMID 34550089›Full record

ArticleJournal of medical Internet research2021

A Road Map for Remote Digital Health Technology for Motor Neuron Disease.

Ruben P A van Eijk, Anita Beelen, Esther T Kruitwagen, Deirdre Murray, Ratko Radakovic, Esther Hobson, Liam Knox, Jochem Helleman, Tom Burke, Miguel Ángel Rubio Pérez and 9 more

Open access · goldAbstract read
In one paragraph

Article in Journal of medical Internet research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Observational
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
  10. The use of digital tools in rare neurological diseases towards a new care model: a narrative review.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 7 countries.

Ruben P A van Eijk *UMC Utrecht Brain Centre, University Medical Centre Utrecht, Utrecht, Netherlands.ORCID 0000-0002-7132-5967
Anita BeelenDepartment of Rehabilitation, University Medical Centre Utrecht, Utrecht, Netherlands.ORCID 0000-0002-1269-0710
Esther T KruitwagenDepartment of Rehabilitation, University Medical Centre Utrecht, Utrecht, Netherlands.ORCID 0000-0002-5930-9681
Deirdre MurrayAcademic Unit of Neurology, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0002-4314-4480
Ratko RadakovicFaculty of Medicine and Health Sciences, University of East Anglia, Norwich, United Kingdom.ORCID 0000-0001-9425-3639
Esther HobsonDepartment of Neuroscience, Sheffield Institute for Translational Neuroscien, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0002-8497-2338
Liam KnoxDepartment of Neuroscience, Sheffield Institute for Translational Neuroscien, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0003-2545-1046
Jochem HellemanDepartment of Rehabilitation, University Medical Centre Utrecht, Utrecht, Netherlands.ORCID 0000-0002-3651-2564
Tom BurkeAcademic Unit of Neurology, Trinity College Dublin, Dublin, Ireland.ORCID 0000-0002-6563-1597
Miguel Ángel Rubio PérezServicio de Neurología, Hospital del Mar, Barcelona, Spain.ORCID 0000-0003-0735-6854
Evy ReviersEuropean Organization for Professionals and Patients with ALS (EUpALS), Leuven, Belgium.ORCID 0000-0002-6044-5234
Angela GengeDepartment of Neurology, Montreal Neurological Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0001-5587-9946
Frederik J SteynSchool of Biomedical Sciences, Faculty of Medicine, University of Queensland, Brisbane, Australia.ORCID 0000-0002-4782-3608
Shyuan NgoThe Royal Brisbane and Women's Hospital, Herston, Australia.ORCID 0000-0002-1388-2108
John EagleshamAdvanced Digital Innovation (UK) Ltd, Salts Mill, United Kingdom.ORCID 0000-0001-8787-6571
Kit C B RoesDepartment of Health Evidence, Section Biostatistics, Radboud Medical Centre Nijmegen, Nijmegen, Netherlands.ORCID 0000-0002-6775-1963
Leonard H van den BergUMC Utrecht Brain Centre, University Medical Centre Utrecht, Utrecht, Netherlands.ORCID 0000-0002-5203-9674
Orla HardimanDepartment of Neurology, National Neuroscience Centre, Beaumont Hospital, Dublin, Ireland.ORCID 0000-0003-2610-1291
Christopher J McDermottDepartment of Neuroscience, Sheffield Institute for Translational Neuroscien, University of Sheffield, Sheffield, United Kingdom.ORCID 0000-0002-1269-9053
University Medical Center Utrecht · NLUniversity of Sheffield · GBThe University of Queensland · AUTrinity College Dublin · IEAdvanced Digital Innovation (United Kingdom) · GBEuropean Federation of Allergy and Airways Diseases Patients Associations · BEHospital Del Mar · ESMontreal Neurological Institute and Hospital · CARadboud University Nijmegen · NLRoyal College of Surgeons in Ireland · IEUniversity of East Anglia · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite recent and potent technological advances, the real-world implementation of remote digital health technology in the care and monitoring of patients with motor neuron disease has not yet been realized. Digital health technology may increase the accessibility to and personalization of care, whereas remote biosensors could optimize the collection of vital clinical parameters, irrespective of patients' ability to visit the clinic. To facilitate the wide-scale adoption of digital health care technology and to align current initiatives, we outline a road map that will identify clinically relevant digital parameters; mediate the development of benefit-to-burden criteria for innovative technology; and direct the validation, harmonization, and adoption of digital health care technology in real-world settings. We define two key end products of the road map: (1) a set of reliable digital parameters to capture data collected under free-living conditions that reflect patient-centric measures and facilitate clinical decision making and (2) an integrated, open-source system that provides personalized feedback to patients, health care providers, clinical researchers, and caregivers and is linked to a flexible and adaptable platform that integrates patient data in real time. Given the ever-changing care needs of patients and the relentless progression rate of motor neuron disease, the adoption of digital health care technology will significantly benefit the delivery of care and accelerate the development of effective treatments.

Indexed as

Motor Neuron DiseaseBiomedical TechnologyCaregiversHealth PersonnelHumansTechnologyamyotrophic lateral sclerosisdigital health care technologye-health

Identifiers

PMID34550089
PMCPMC8495582
OpenAlexW3164881118

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.